Altimmune, Inc. (ALT)

PriceLoading quote

Financial charts

Revenue

Net income

Free cash flow

Total cash / debt

CashTotal debt

Financial statements

16 annual periodsNewest to oldest
2025202420232022202120202019201820172016201520142013201220112010
Revenue$41,000$20,000$426,000−$68,000$4.4M$8.2M$5.8M$10.3M$10.7M$3.2M$24.3M$21.0M
Research & development$66.4M$82.2M$65.8M$70.5M$74.5M$49.8M$17.8M$18.5M$18.4M$7.2M$5.1M$9.3M$15.3M$19.5M$21.2M$20.9M
Operating expenses$94.5M$103.2M$96.4M$87.7M$101.3M$63.0M$27.3M$53.2M$62.8M$14.3M$14.0M$20.4M$28.8M$31.4M$36.0M$44.5M
Operating income−$94.5M−$103.2M−$95.9M−$87.7M−$96.9M−$54.8M−$21.5M−$42.8M−$52.0M−$11.1M−$3.4M−$10.2M−$10.8M−$6.3M−$11.7M−$23.6M
EBITDAderived−$96.4M−$54.4M−$21.1M−$6.0M−$11.3M−$22.5M
Net income−$88.1M−$95.1M−$88.4M−$84.7M−$97.1M−$49.0M−$20.5M−$39.2M−$46.4M−$11.1M−$3.4M−$10.0M−$11.7M−$4.9M−$3.8M−$34.8M
Basic EPSper diluted share-$1.00-$1.34-$1.66-$1.81-$2.35-$1.91-$1.60-$15.16-$118.91$2.97-$0.05-$0.17-$0.23-$0.10-$0.08-$1.08
Diluted EPSper diluted share-$1.00-$1.34-$1.66-$1.81-$2.35-$1.91-$1.60-$15.16-$118.91$2.95-$0.05-$0.17-$0.23-$0.10-$0.08-$1.08

Insider buys & sells

Jul 1, 2024Jun 30, 2026
Buys12$383.6K disclosed value
Sells (SEC code S)2$110.5K disclosed value
14 recent transactions
TransactionInsiderTypeSharesPriceValueOwned after
Apr 6, 2026Form 4GILL JOHNDirectorBuyCommon Stock, par value $0.00019.2K$3.41$31.4K21.7K
Apr 1, 2026Form 4Durso Jerome BenedictPresident and CEOBuyCommon Stock, par value $0.000115.0K$3.14$47.1K47.5K
Apr 1, 2026Form 4WEAVER GREGORY LChief Financial OfficerBuyCommon Stock, par value $0.000110.0K$3.15$31.5K38.1K
Mar 6, 2026Form 4Durso Jerome BenedictPresident and CEOBuyCommon Stock, par value $0.000120.0K$3.54$70.8K32.5K
Mar 6, 2026Form 4WEAVER GREGORY LChief Financial OfficerBuyCommon Stock, par value $0.00015.0K$3.54$17.7K28.1K